ICON PLC
ICLR169.190USD
-12.310-6.78%
Close 07/31, 16:00（ET）Quotes delayed by 15 min
13.16BMarket Cap
17.35P/E TTM
More Details of ICON PLC Company
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Company Info
Ticker SymbolICLR
Company nameICON PLC
IPO dateMay 15, 1998
Founded at1989
CEODr. Stephen (Steve) Cutler, Ph.D.
Number of employees41900
Security typeOrdinary Share
Fiscal year-endMay 15
AddressSouth County Business Park
CityDUBLIN
Stock exchangeNASDAQ Global Select Consolidated
CountryIreland
Postal code- -
Phone35312912000
Websitehttps://www.iconplc.com/
Ticker SymbolICLR
IPO dateMay 15, 1998
Founded at1989
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Barry Edward Balfe
Mr. Barry Edward Balfe
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Anne C. Whitaker
Ms. Anne C. Whitaker
Independent Director
Independent Director
--
--
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Ronan Murphy
Mr. Ronan Murphy
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Ireland
722.90M
36.12%
United States
671.73M
33.56%
Rest of Europe
374.01M
18.69%
Rest of the World
232.69M
11.63%
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Jul 24
Updated: Thu, Jul 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Artisan Partners Limited Partnership
5.52%
Wellington Management Company, LLP
4.75%
Ninety One UK Limited
3.85%
MFS Investment Management
3.63%
Invesco Advisers, Inc.
3.19%
Other
79.06%
Shareholders
Shareholders
Proportion
Artisan Partners Limited Partnership
5.52%
Wellington Management Company, LLP
4.75%
Ninety One UK Limited
3.85%
MFS Investment Management
3.63%
Invesco Advisers, Inc.
3.19%
Other
79.06%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
42.92%
Investment Advisor
35.79%
Hedge Fund
8.82%
Research Firm
2.44%
Pension Fund
2.35%
Bank and Trust
1.47%
Sovereign Wealth Fund
1.29%
Family Office
1.09%
Family Office
1.09%
Other
2.72%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1327
74.75M
96.11%
-11.06M
2025Q1
1362
81.04M
101.97%
-5.18M
2024Q4
1334
80.88M
97.97%
-5.29M
2024Q3
1290
83.28M
100.86%
-2.02M
2024Q2
1273
83.12M
100.37%
-2.47M
2024Q1
1254
83.08M
100.49%
-3.81M
2023Q4
1237
84.94M
102.98%
-3.00M
2023Q3
1213
86.31M
104.85%
-1.65M
2023Q2
1199
85.95M
104.64%
+2.46M
2023Q1
1190
81.67M
99.73%
-2.49M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Artisan Partners Limited Partnership
4.29M
5.4%
+4.10M
+2097.19%
Mar 31, 2025
Wellington Management Company, LLP
3.69M
4.65%
+1.58M
+74.76%
Mar 31, 2025
Ninety One UK Limited
2.92M
3.67%
-28.77K
-0.98%
Mar 31, 2025
MFS Investment Management
2.83M
3.56%
-61.65K
-2.13%
Mar 31, 2025
Invesco Advisers, Inc.
2.48M
3.12%
+1.10M
+79.31%
Mar 31, 2025
AllianceBernstein L.P.
1.86M
2.34%
+39.46K
+2.17%
Mar 31, 2025
ClearBridge Investments, LLC
1.84M
2.32%
-207.52K
-10.11%
Mar 31, 2025
Templeton Investment Counsel, L.L.C.
1.81M
2.28%
-69.99K
-3.72%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.66M
2.09%
+545.53K
+48.87%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.57M
1.97%
+559.38K
+55.54%
Mar 31, 2025
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
iShares MSCI Ireland ETF
4.41%
Polen Capital International Growth ETF
4.14%
VanEck Biotech ETF
2.9%
Polen Capital Global Growth ETF
2.5%
Harbor Health Care ETF
2.27%
Running Oak Efficient Growth ETF
1.72%
Janus Henderson US Sustainable Equity ETF
1.47%
Motley Fool Global Opportunities ETF
1.22%
FPA Global Equity ETF
1.07%
Invesco ESG NASDAQ Next Gen 100 ETF
0.91%
View more
iShares MSCI Ireland ETF
Proportion4.41%
Polen Capital International Growth ETF
Proportion4.14%
VanEck Biotech ETF
Proportion2.9%
Polen Capital Global Growth ETF
Proportion2.5%
Harbor Health Care ETF
Proportion2.27%
Running Oak Efficient Growth ETF
Proportion1.72%
Janus Henderson US Sustainable Equity ETF
Proportion1.47%
Motley Fool Global Opportunities ETF
Proportion1.22%
FPA Global Equity ETF
Proportion1.07%
Invesco ESG NASDAQ Next Gen 100 ETF
Proportion0.91%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
